share_log

bluebird bio: bluebird bio, Inc. - Reverse Split Option Symbol: BLUE New Symbol: BLUE1

bluebird bio: bluebird bio, Inc. - Reverse Split Option Symbol: BLUE New Symbol: BLUE1

bluebird bio:bluebird bio公司 - 反向拆分選項 標的: BLUE 新標的: BLUE1
OCC期權清算公司 ·  12/12 02:32

牛牛AI助理已提取核心訊息

bluebird bio, Inc. has announced a 1-for-20 reverse stock split, effective December 13, 2024. The company's stock symbol will change from BLUE to BLUE1 on the effective date. This corporate action will impact the company's options contracts.As a result of the reverse split, the new contract multiplier for options will be 100, and the new deliverable per contract will be 5 new bluebird bio common shares. The underlying price for BLUE1 options will be calculated as 0.05 times the price of BLUE. The new CUSIP for bluebird bio shares will be 09609G209.Option investors are advised to independently evaluate this corporate event and its impact on their investments. The Options Clearing Corporation (OCC) will make adjustments to options and futures based on their by-laws, and these decisions may be subject to change as more information becomes available.
bluebird bio, Inc. has announced a 1-for-20 reverse stock split, effective December 13, 2024. The company's stock symbol will change from BLUE to BLUE1 on the effective date. This corporate action will impact the company's options contracts.As a result of the reverse split, the new contract multiplier for options will be 100, and the new deliverable per contract will be 5 new bluebird bio common shares. The underlying price for BLUE1 options will be calculated as 0.05 times the price of BLUE. The new CUSIP for bluebird bio shares will be 09609G209.Option investors are advised to independently evaluate this corporate event and its impact on their investments. The Options Clearing Corporation (OCC) will make adjustments to options and futures based on their by-laws, and these decisions may be subject to change as more information becomes available.
bluebird bio, Inc. 宣佈將於2024年12月13日實施1比20的反向股票拆分。公司的股票標的將從BLUE更改爲BLUE1,生效日期爲該日期。此項企業行動將影響公司的期權合同。由於反向拆分,期權的新合同乘數將爲100,每份合同的新交付物將爲5股新的bluebird bio普通股。BLUE1期權的基礎價格將按BLUE價格的0.05倍計算。bluebird bio股票的新CUSIP將爲09609G209。期權投資者被建議獨立評估此企業事件及其對他們投資的影響。期權清算公司(OCC)將根據其章程對期權和期貨進行調整,這些決定可能會隨着更多信息的公佈而發生變化。
bluebird bio, Inc. 宣佈將於2024年12月13日實施1比20的反向股票拆分。公司的股票標的將從BLUE更改爲BLUE1,生效日期爲該日期。此項企業行動將影響公司的期權合同。由於反向拆分,期權的新合同乘數將爲100,每份合同的新交付物將爲5股新的bluebird bio普通股。BLUE1期權的基礎價格將按BLUE價格的0.05倍計算。bluebird bio股票的新CUSIP將爲09609G209。期權投資者被建議獨立評估此企業事件及其對他們投資的影響。期權清算公司(OCC)將根據其章程對期權和期貨進行調整,這些決定可能會隨着更多信息的公佈而發生變化。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。